GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Canopy Growth Corp (TSX:WEED) » Definitions » Equity-to-Asset

Canopy Growth (TSX:WEED) Equity-to-Asset : 0.40 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Canopy Growth Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Canopy Growth's Total Stockholders Equity for the quarter that ended in Dec. 2023 was C$544.5 Mil. Canopy Growth's Total Assets for the quarter that ended in Dec. 2023 was C$1,359.8 Mil. Therefore, Canopy Growth's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.40.

The historical rank and industry rank for Canopy Growth's Equity-to-Asset or its related term are showing as below:

TSX:WEED' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.31   Med: 0.73   Max: 1
Current: 0.4

During the past 13 years, the highest Equity to Asset Ratio of Canopy Growth was 1.00. The lowest was 0.31. And the median was 0.73.

TSX:WEED's Equity-to-Asset is ranked worse than
71.88% of 1088 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs TSX:WEED: 0.40

Canopy Growth Equity-to-Asset Historical Data

The historical data trend for Canopy Growth's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Canopy Growth Equity-to-Asset Chart

Canopy Growth Annual Data
Trend Jul13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.79 0.71 0.51 0.64 0.31

Canopy Growth Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.31 0.39 0.45 0.40

Competitive Comparison of Canopy Growth's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Canopy Growth's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Canopy Growth's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Canopy Growth's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Canopy Growth's Equity-to-Asset falls into.



Canopy Growth Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Canopy Growth's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Equity to Asset (A: Mar. 2023 )=Total Stockholders Equity/Total Assets
=758.435/2439.098
=0.31

Canopy Growth's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=544.524/1359.751
=0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Canopy Growth  (TSX:WEED) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Canopy Growth Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Canopy Growth's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Canopy Growth (TSX:WEED) Business Description

Traded in Other Exchanges
Address
1 Hershey Drive, Smiths Falls, ON, CAN, K7A 0A8
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include sports drink BioSteel, skincare products under This Works, Martha Stewart CBD, and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

Canopy Growth (TSX:WEED) Headlines